Our previous work [23, 24] showed that, in the development of APL, both the targets and the expression level of PU.1 are inhibited by the oncogenic PML-RARα fusion protein, which is generated by the chromosomal translocation, t(15;17). The gene discussed is PML; the disease is acute promyelocytic leukemia.